160 related articles for article (PubMed ID: 34822033)
1. USP39 attenuates the antitumor activity of cisplatin on colon cancer cells dependent on p53.
Yuan J; Li X; Zhang Y; Zhang G; Cheng W; Wang W; Lei Y; Song G
Cell Biol Toxicol; 2023 Oct; 39(5):1995-2010. PubMed ID: 34822033
[TBL] [Abstract][Full Text] [Related]
2. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
Yuan J; Li X; Zhang G; Cheng W; Wang W; Lei Y; Ma Q; Song G
Mol Carcinog; 2021 Apr; 60(4):265-278. PubMed ID: 33634905
[TBL] [Abstract][Full Text] [Related]
3. Knocking down USP39 Inhibits the Growth and Metastasis of Non-Small-Cell Lung Cancer Cells through Activating the p53 Pathway.
Yuan J; Zhang G; Li X; Ma Q; Cheng W; Wang W; Zhang B; Hu T; Song G
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255748
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-specific peptidase 39 regulates the process of proliferation and migration of human ovarian cancer via p53/p21 pathway and EMT.
Yan C; Yuan J; Xu J; Zhang G; Li X; Zhang B; Hu T; Huang X; Mao Y; Song G
Med Oncol; 2019 Oct; 36(11):95. PubMed ID: 31637536
[TBL] [Abstract][Full Text] [Related]
5. USP39 regulates DNA damage response and chemo-radiation resistance by deubiquitinating and stabilizing CHK2.
Wu J; Chen Y; Geng G; Li L; Yin P; Nowsheen S; Li Y; Wu C; Liu J; Zhao F; Kim W; Zhou Q; Huang J; Guo G; Zhang C; Tu X; Gao X; Lou Z; Luo K; Qiao H; Yuan J
Cancer Lett; 2019 May; 449():114-124. PubMed ID: 30771428
[TBL] [Abstract][Full Text] [Related]
6. USP39 Deubiquitinase Is Essential for
Fraile JM; Manchado E; Lujambio A; Quesada V; Campos-Iglesias D; Webb TR; Lowe SW; López-Otín C; Freije JM
J Biol Chem; 2017 Mar; 292(10):4164-4175. PubMed ID: 28154181
[No Abstract] [Full Text] [Related]
7. Ubiquitin-specific protease 39 is overexpressed in human lung cancer and promotes tumor cell proliferation in vitro.
Lin Z; Xiong L; Lin Q
Mol Cell Biochem; 2016 Nov; 422(1-2):97-107. PubMed ID: 27629785
[TBL] [Abstract][Full Text] [Related]
8. miR-381 Inhibits Proliferation and Invasion of Non-Small-Cell Cancer Cells by Targeting USP39.
Cui F; Luo P; Wu R; Meng J
Dis Markers; 2022; 2022():2195393. PubMed ID: 36046375
[TBL] [Abstract][Full Text] [Related]
9. MyD88 in DNA repair and cancer cell resistance to genotoxic drugs.
Kfoury A; Le Corf K; El Sabeh R; Journeaux A; Badran B; Hussein N; Lebecque S; Manié S; Renno T; Coste I
J Natl Cancer Inst; 2013 Jul; 105(13):937-46. PubMed ID: 23766530
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of ING4 and P53 enhances hypopharyngeal cancer chemosensitivity to cisplatin in vivo.
Ren X; Liu H; Zhang M; Wang M; Ma S
Mol Med Rep; 2016 Sep; 14(3):2431-8. PubMed ID: 27484725
[TBL] [Abstract][Full Text] [Related]
11. USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance.
Wang L; Chen T; Li X; Yan W; Lou Y; Liu Z; Chen H; Cui Z
Int J Oncol; 2019 Jul; 55(1):277-288. PubMed ID: 31180526
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p/S100A4/p53 axis.
Liu Y; Yang C; Zhao Y; Chi Q; Wang Z; Sun B
Aging (Albany NY); 2019 Dec; 11(24):12328-12344. PubMed ID: 31866582
[TBL] [Abstract][Full Text] [Related]
13. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2004 Aug; 12(2):357-61. PubMed ID: 15254702
[TBL] [Abstract][Full Text] [Related]
14. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
15. Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin.
Gavin EJ; Song B; Wang Y; Xi Y; Ju J
PLoS One; 2008; 3(12):e4054. PubMed ID: 19112505
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X
Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
18. USP39 regulates the cell cycle, survival, and growth of human leukemia cells.
Liu C; Yao X; Li M; Xi Y; Zhao L
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898977
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of ubiquitin-specific peptidase 39 inhibited the growth of osteosarcoma cells and induced apoptosis in vitro.
Gan Z; Han K; Lin S; Hu H; Shen Z; Min D
Biol Res; 2017 Apr; 50(1):15. PubMed ID: 28403900
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma.
Ali S; Tahir M; Khan AA; Chen XC; Ling M; Huang Y
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30841620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
